| Safeway Pharmacy #1459 | |
| 4370 Montgomery Rd, Ellicott City, Maryland 21043 | |
| (410) 203-1212 |
| Name | Safeway Pharmacy #1459 |
|---|---|
| Organization Name | Nai Saturn Eastern Llc |
| Location | 4370 Montgomery Rd, Ellicott City, Maryland 21043 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (410) 203-1212 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In the future, even before the start of the treatment, physicians will be able to establish how patient's blood binds a given medicine and what doze should be applied in order to obtain the concentration in the body that would be optimal for the treatment. A new simple method of analysis of chemical reactions proceeding in solutions has been developed in the Institute of Physical Chemistry of the Polish Academy of Sciences.
Cyberonics, Inc. today announced that the United States Food and Drug Administration (FDA) has approved its re-designed AspireHC (High Capacity) generator, which was the subject of a voluntary product withdrawal in August 2011.
Over the coming weeks, the Professional Association of Internes and Residents of Ontario (PAIRO) will play host to over 90 Ontario communities in need during the Health Professionals Recruitment Tour. Communities, experiencing a shortage of doctors, nurses and other healthcare providers will take the opportunity to showcase lifestyle, educational and employment opportunities available. Last year, over 1200 students, residents and established healthcare professionals visited the job fair.
The Tuberous Sclerosis Alliance (TS Alliance) today announced the first drug approved for a tuberous sclerosis complex (TSC) indication by the Federal Drug Administration (FDA). This drug, manufactured by Novartis Oncology, is called Afinitor and will be used to treat subependymal giant cell astrocytomas (SEGAs) in individuals with TSC.
The combination of augmented reality technology, geocaching, and other novel techniques to create innovative active video games (AVGs) has potential personal and public health implications, as discussed in the Editorial "Pokémon Go, Go, Go, Gone? (http://online.liebertpub.com/doi/full/10.1089/g4h.2016.01055.tbp)" published in Games for Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
› Verified 6 days ago
| NPI Number | 1013778315 |
| Organization Name | NAI SATURN EASTERN LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 4370 Montgomery Rd, Ellicott City, MD 21043 |
| Phone Number | 410-203-1212 |
News Archive
In the future, even before the start of the treatment, physicians will be able to establish how patient's blood binds a given medicine and what doze should be applied in order to obtain the concentration in the body that would be optimal for the treatment. A new simple method of analysis of chemical reactions proceeding in solutions has been developed in the Institute of Physical Chemistry of the Polish Academy of Sciences.
Cyberonics, Inc. today announced that the United States Food and Drug Administration (FDA) has approved its re-designed AspireHC (High Capacity) generator, which was the subject of a voluntary product withdrawal in August 2011.
Over the coming weeks, the Professional Association of Internes and Residents of Ontario (PAIRO) will play host to over 90 Ontario communities in need during the Health Professionals Recruitment Tour. Communities, experiencing a shortage of doctors, nurses and other healthcare providers will take the opportunity to showcase lifestyle, educational and employment opportunities available. Last year, over 1200 students, residents and established healthcare professionals visited the job fair.
The Tuberous Sclerosis Alliance (TS Alliance) today announced the first drug approved for a tuberous sclerosis complex (TSC) indication by the Federal Drug Administration (FDA). This drug, manufactured by Novartis Oncology, is called Afinitor and will be used to treat subependymal giant cell astrocytomas (SEGAs) in individuals with TSC.
The combination of augmented reality technology, geocaching, and other novel techniques to create innovative active video games (AVGs) has potential personal and public health implications, as discussed in the Editorial "Pokémon Go, Go, Go, Gone? (http://online.liebertpub.com/doi/full/10.1089/g4h.2016.01055.tbp)" published in Games for Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
› Verified 6 days ago
| NPI Number | 1841236478 |
| Organization Name | NAI SATURN EASTERN LLC |
| Doing Business As | SAFEWAY PHARMACY #1459 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 4370 Montgomery Rd, Ellicott City, MD 21043 |
| Phone Number | 410-203-1212 |
News Archive
In the future, even before the start of the treatment, physicians will be able to establish how patient's blood binds a given medicine and what doze should be applied in order to obtain the concentration in the body that would be optimal for the treatment. A new simple method of analysis of chemical reactions proceeding in solutions has been developed in the Institute of Physical Chemistry of the Polish Academy of Sciences.
Cyberonics, Inc. today announced that the United States Food and Drug Administration (FDA) has approved its re-designed AspireHC (High Capacity) generator, which was the subject of a voluntary product withdrawal in August 2011.
Over the coming weeks, the Professional Association of Internes and Residents of Ontario (PAIRO) will play host to over 90 Ontario communities in need during the Health Professionals Recruitment Tour. Communities, experiencing a shortage of doctors, nurses and other healthcare providers will take the opportunity to showcase lifestyle, educational and employment opportunities available. Last year, over 1200 students, residents and established healthcare professionals visited the job fair.
The Tuberous Sclerosis Alliance (TS Alliance) today announced the first drug approved for a tuberous sclerosis complex (TSC) indication by the Federal Drug Administration (FDA). This drug, manufactured by Novartis Oncology, is called Afinitor and will be used to treat subependymal giant cell astrocytomas (SEGAs) in individuals with TSC.
The combination of augmented reality technology, geocaching, and other novel techniques to create innovative active video games (AVGs) has potential personal and public health implications, as discussed in the Editorial "Pokémon Go, Go, Go, Gone? (http://online.liebertpub.com/doi/full/10.1089/g4h.2016.01055.tbp)" published in Games for Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
› Verified 6 days ago
| NPI Number | 1952912321 |
| Organization Name | NAI SATURN EASTERN LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 4370 Montgomery Rd, Ellicott City, MD 21043 |
| Phone Number | 410-203-1212 |
News Archive
In the future, even before the start of the treatment, physicians will be able to establish how patient's blood binds a given medicine and what doze should be applied in order to obtain the concentration in the body that would be optimal for the treatment. A new simple method of analysis of chemical reactions proceeding in solutions has been developed in the Institute of Physical Chemistry of the Polish Academy of Sciences.
Cyberonics, Inc. today announced that the United States Food and Drug Administration (FDA) has approved its re-designed AspireHC (High Capacity) generator, which was the subject of a voluntary product withdrawal in August 2011.
Over the coming weeks, the Professional Association of Internes and Residents of Ontario (PAIRO) will play host to over 90 Ontario communities in need during the Health Professionals Recruitment Tour. Communities, experiencing a shortage of doctors, nurses and other healthcare providers will take the opportunity to showcase lifestyle, educational and employment opportunities available. Last year, over 1200 students, residents and established healthcare professionals visited the job fair.
The Tuberous Sclerosis Alliance (TS Alliance) today announced the first drug approved for a tuberous sclerosis complex (TSC) indication by the Federal Drug Administration (FDA). This drug, manufactured by Novartis Oncology, is called Afinitor and will be used to treat subependymal giant cell astrocytomas (SEGAs) in individuals with TSC.
The combination of augmented reality technology, geocaching, and other novel techniques to create innovative active video games (AVGs) has potential personal and public health implications, as discussed in the Editorial "Pokémon Go, Go, Go, Gone? (http://online.liebertpub.com/doi/full/10.1089/g4h.2016.01055.tbp)" published in Games for Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
› Verified 6 days ago
News Archive
In the future, even before the start of the treatment, physicians will be able to establish how patient's blood binds a given medicine and what doze should be applied in order to obtain the concentration in the body that would be optimal for the treatment. A new simple method of analysis of chemical reactions proceeding in solutions has been developed in the Institute of Physical Chemistry of the Polish Academy of Sciences.
Cyberonics, Inc. today announced that the United States Food and Drug Administration (FDA) has approved its re-designed AspireHC (High Capacity) generator, which was the subject of a voluntary product withdrawal in August 2011.
Over the coming weeks, the Professional Association of Internes and Residents of Ontario (PAIRO) will play host to over 90 Ontario communities in need during the Health Professionals Recruitment Tour. Communities, experiencing a shortage of doctors, nurses and other healthcare providers will take the opportunity to showcase lifestyle, educational and employment opportunities available. Last year, over 1200 students, residents and established healthcare professionals visited the job fair.
The Tuberous Sclerosis Alliance (TS Alliance) today announced the first drug approved for a tuberous sclerosis complex (TSC) indication by the Federal Drug Administration (FDA). This drug, manufactured by Novartis Oncology, is called Afinitor and will be used to treat subependymal giant cell astrocytomas (SEGAs) in individuals with TSC.
The combination of augmented reality technology, geocaching, and other novel techniques to create innovative active video games (AVGs) has potential personal and public health implications, as discussed in the Editorial "Pokémon Go, Go, Go, Gone? (http://online.liebertpub.com/doi/full/10.1089/g4h.2016.01055.tbp)" published in Games for Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
› Verified 6 days ago
Rite Aid Pharmacy 00384 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8601 Baltimore National Pike, Ellicott City, Maryland 21043 Phone: (410) 480-1377 | |
Enchanted Medical Llc Type: DME Supplier - Dialysis Equipment & Supplies Location: 10040 Baltimore National Pike, Ellicott City, Maryland 21042 Phone: (410) 988-8740 | |
Cvs Pharmacy # 02043 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3300a Centennial Lane, Ellicott City, Maryland 21042 Phone: (410) 750-9439 | |
Cvs Pharmacy #16427 Type: Community/Retail Pharmacy Location: 4390 Montgomery Rd, Ellicott City, Maryland 21043 Phone: (410) 203-1171 | |
Walgreens#17905 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9150 Baltimore National Pike, Ellicott City, Maryland 21042 Phone: (410) 465-4666 |